The Exchange has sought clarification from Sakar Healthcare Limited for the quarter ended 31-Mar-2026 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: The response of the Company is awaited.
SAKAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The National Stock Exchange (NSE) has asked Sakar Healthcare Limited to provide clarification regarding its financial results filing for the quarter ending March 31, 2026, under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has not yet submitted its response to the exchange query. This appears to be a routine regulatory compliance matter where the exchange requests additional details or clarification on the company's quarterly financial disclosure. No specific reason for the query or details of what needs clarification have been disclosed.
This is a standard regulatory query and does not indicate any immediate penalty or adverse action. The outcome will depend on the company's response and whether the exchange is satisfied with the clarification provided. Shareholders should monitor for the company's response and any follow-up action from the exchange.